期刊文献+

系统性红斑狼疮患者干扰素诱导基因的表达及其与疾病活动陛的相关性研究 被引量:2

Expressions of interferon-inducible genes in patients with systemic lupus erythematosus and their assoc-iation with disease activity
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者外周血单个核细胞(PBMCs)中5个干扰素(IFN)诱导基因(IFIT1、IFIT4、OAS1、OASL、ISG15)的表达及其与SLE疾病活动度的相关性。方法运用SYBRgreendveI实时定量聚合酶链反应(RT—PCR)方法检测76例SLE患者与54名健康对照人的IFIT1、IFIT4、OASI、OASL及ISG15 mRNA表达水平(以-△△Ct值表示),并且与红细胞沉降率(ESR)、C反应蛋白(CRP)、补体C3、C4、抗核抗体(ANA)及抗dsDNA抗体等指标比较,分析IFIT1、IFIT4、OAS1、OASL、ISG15mRNA表达水平以及上述常规检测指标与SLE疾病活动指数(SLEDA1)积分之间的相关性。结果①SLE组与正常对照组相比,IFIT1、IFIT4、OAS1、OASL及ISG15mRNA表达显著增高(P〈0.01);SLE活动组与SLE缓解组比较,IFIT1、IFIT4、OAS1、OASL及ISG15 mRNA表达增高(P〈0.05);SLE组IFIT1、IFIT4、OAS1、OASL及ISG15 mRNA表达水平之间呈正相关(r〉0.5,P〈0.05)。@SLE组IFITl、IFIT4、OASl、OASL及ISGl5mRNA表达水平均与SLEDAI积分呈显著正相关(r〉0.5,P〈0.05)。③ESR、CRP、补体c3、C4、ANA与IFIT1、IFIT4、OAS1、OASL、ISG15m RNA表达水平及SLEDAI积分均无相关性,抗dsDNA抗体与IFIT1、IFIT4、OAS1、OASL、ISG15 mRNA表达水平及SLEDAI积分呈正相关(r〉0.5,P〈0.05)。结论SLE患者IFIT1、IFIT4、OAS1、OASL及ISG15的表达水平在SLE患者中显著增高,并且与SLEDA1积分呈显著正相关,对SLE患者病情活动度和病情严重度的判断均有较大价值,抑制这5个基因的表达可能为SLE的治疗提供新的靶点。 Objective To investigate the expression levels of interferon-inducible genes (IFIT1, 1FIT4, OAS1, OASL, ISG15) in the peripheral blood mononuelear cells (PBMCs) of patients with systemic lupus erythematosus (SLE), and the relations between these genes expression levels and disease activity are explored. Methods Sybr green dye based real-time quantitative PCR method was used to detect the expression levels (indicated as -△△Ct value) of IFIT1, IFIT4, OAS1, OASL and ISG15 in 76 patients with SLE and 54 controls. Their expression levels were compared with erythrocyte sedimentation rate (ESR), serum C reactive protein (CRP), complement C3, C4, antinuclear antibody (ANA), anti-double stranded DNA antibody. The associations between the expression levels of IFIT1, IFIT4, OAS1, OASL, ISG15, ESR, CRP, complement C3, C4, ANA, anti-double stranded DNA antibody and SLEDAI scores in patients with SLE were analyzed. Results①The expression levels of IFIT1, IFIT4, OAS1, OASL and ISG15 in the SLE patients were significantly higher than those of the normal controls (P〈0.01). The expression levels of IFIT1, IFIT4, OAS1, OASL and ISG15 in active SLE patients were higher than those of inactive SLE patients (P〈 0.05). The real time expression levels of IFIT1, IFIT4, OAS1, OASL and ISG15 showed positive correlations with each other (r〉0.5, P〈0.05) in patients with SLE. ② The expression levels of IFIT1, IFIT4, OAS1, OASL and ISG15 were positively correlated with the SLEDAI scores (r〉0.5, P〈0.05). ③There was no correlation between ESR, CRP, complement C3, C4, ANA and the expression levels of IFIT1, IFIT4, OAS1, OASL, ISG15, SLEDA1 scores except anti-double stranded DNA antibody (r〉0.5, P〈0.05). Conclusion The expression levels of IFIT1, IFIT4, OAS1, OASL and ISG15 in patients with SLE are significantly higher than those of the normal controls, and positively associated with SLEDAI scores, so they are helpful in evaluating SLE disease activity and severity. IFIT1, IFIT4, OAS1, OASL and ISG15 genes may be the potential treating targets for SLE.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2009年第2期93-97,共5页 Chinese Journal of Rheumatology
基金 南京市医学科技发展项目(YKK07033),南京医科大学发展基金(06NMU067)
关键词 红斑狼疮 系统性 干扰素诱导基因 实时定量聚合酶链反应 Lupus erythematosus, systemic Interferon-inducible genes Real-time polymerasechain reaction
  • 相关文献

参考文献25

  • 1Crow MK. Interferon pathway activation in systemic lupus erythematosus. Curr Rheumatol Rep, 2005, 7: 463-468.
  • 2Dall'era MC, Cardarelli PM, Preston BT, et al. Type Ⅰ interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis, 2005, 64: 1692-1697.
  • 3Vallin H, Blomberg S, Alm GV, et al. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol, 1999, 115: 196-202.
  • 4Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev, 2004, 202: 8-32.
  • 5Platanias LC. Mechanisms of type-Ⅰ and type-Ⅱ-interferon-mediated signalling. Nat Rev Immunol, 2005, 5: 375-386.
  • 6Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol, 2001, 2: 378-386.
  • 7Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 1994, 264: 1415-1421.
  • 8Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a muhimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol, 2002, 14: 111-116.
  • 9董怡.系统性红斑狼疮[A].见:叶任高 陆再英 主编.内科学 第6版[C].北京:人民卫生出版社,2004.892-898.
  • 10Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 [-Delta Delta C (T) ] method. Methods, 2001, 25: 402-408.

共引文献6

同被引文献30

  • 1黄新芳,沈南.系统性红斑狼疮基因表达谱的芯片分析[J].上海医学,2004,27(12):943-945. 被引量:1
  • 2Li QZ, Zhou J, Lian Y, et al.Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes [ J ] .Clin Exp Immunol, 2009,159 ( 3 ) : 281-291.
  • 3Dall' era MC, Cardarelli PM, Preston BT, et al.Typel interferon correlates with serological and clinical manifestations of SLE [J]. Ann Rheum Dis, 2005,64 (12) : 1692-1697.
  • 4Qing X, Putterman C.Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus [J ].Autoimmun Rev, 2004,3(7-8) : 505-509.
  • 5Hale MB, Krutzik PO, Samra SS, et al.Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus[J].PLoS One,2009,4(8) : e6756.
  • 6Niewold TB,Clark DN,Salloum R,et al.Interferon alpha in systemic lupus erythematosus [J].J Biomed Biotechnol, 2010,2010 : 948364.
  • 7Baechler EC,Gregersen PK,Behrens TW.The emerging role of interferon in human systemic lupus erythematosus [J].Curr Opin Immunol, 2004,16(6) : 801-807.
  • 8Ronnblom L, Alm GV.Systemic lupus erythematosus and the type I interferon system [ J ].Arthritis Res Ther, 2003,5 (2) : 68-75.
  • 9Ronnblom L,Alm GV.An etiopathogenic role for the type I IFN system in SLE [J].Trends Immunol, 2001,22 (8) : 427-431.
  • 10Crow MK, Ka K.Interferon-ct in systemic lupus erythematosus [J]. Curt Opin Rheumatol, 2004,5 (16) : 541-547.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部